26 May 2025

Diabetes Mental Health Pharmaceuticals

GLP1-RAs don’t worsen mental health

20 May 2025

Diabetes Obesity Opthalmology Pharmaceuticals

Growing concerns over semaglutide, tirzepatide eye stroke link

12 May 2025

Diabetes Pharmaceuticals Weight management

Obesity drug leads to 25% weight loss in a third of patients

12 May 2025

Diabetes Obesity

Diabetes a bigger problem than we thought

7 May 2025

Clinical Diabetes

Low-carb, healthy-fat diet and optimising metabolic health

31 March 2025

Cardiology Clinical Diabetes

Coming up: SGLT2s to reduce cardiovascular death in T2D

31 March 2025

Cardiology Diabetes PBS

Expanded PBS listing for empagliflozin

24 March 2025

Diabetes Obesity Pharmaceuticals

Why microdosing GLP-1s is not OK

24 March 2025

Clinical Diabetes Obesity PBAC The Hill

PBAC spurns tirzepatide for subsidy, again

13 March 2025

Clinical Diabetes Endocrinology

Coming up: Preventing renal failure in type 2 diabetes

10 March 2025

Diabetes Medicare Obesity Political

DoHAC targets GLP-1 docs

19 February 2025

Diabetes Election 2025 Technology

‘Urgent’ need for more equitable access to diabetes tech

21 January 2025

Cardiology Diabetes Pharmaceuticals

What Ozempic is and isn’t good for

5 December 2024

Clinical Diabetes Obesity

Even more things GLP-1 RAs can do

25 November 2024

Clinical Diabetes

Don’t risk these drugs in type 1 diabetes patients

25 November 2024

Diabetes Political Technology

‘Unnecessarily created’ barriers stop GPs providing diabetes tech